Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425881
Max Phase: Preclinical
Molecular Formula: C27H35N3O3
Molecular Weight: 449.60
Molecule Type: Small molecule
Associated Items:
ID: ALA2425881
Max Phase: Preclinical
Molecular Formula: C27H35N3O3
Molecular Weight: 449.60
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@]12CC[C@H](OC(=O)C3CCC3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cncn3)=C(C=O)C[C@@H]12
Standard InChI: InChI=1S/C27H35N3O3/c1-26-10-8-20(33-25(32)17-4-3-5-17)13-19(26)6-7-21-22(26)9-11-27(2)23(21)12-18(14-31)24(27)30-16-28-15-29-30/h6,14-17,20-23H,3-5,7-13H2,1-2H3/t20-,21+,22-,23-,26-,27-/m0/s1
Standard InChI Key: NVMTZMJRQZQKOF-SXUTZIHKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 449.60 | Molecular Weight (Monoisotopic): 449.2678 | AlogP: 4.97 | #Rotatable Bonds: 4 |
Polar Surface Area: 74.08 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.61 | CX LogP: 3.64 | CX LogD: 3.64 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.37 | Np Likeness Score: 0.75 |
1. Garrido M, Cabeza M, Cortés F, Gutiérrez J, Bratoeff E.. (2013) Cytotoxic effect of novel dehydroepiandrosterone derivatives on different cancer cell lines., 68 [PMID:23994323] [10.1016/j.ejmech.2013.02.031] |
Source(1):